Reach Us +44-1647-403003
Signature-guided Approaches For Targeting DNA Damage Response Defects In Cancer | 95094
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Signature-guided approaches for targeting DNA damage response defects in cancer

International Conference on Cancer Diagnosis & Treatment

Shiaw-Yih Lin

The University of Texas MD AndersonCancer Center, USA

Keynote: J Cancer Sci Ther

DOI: 10.4172/1948-5956-C9-146

Defects of DNA damage response are considered as a hallmark of human cancer. Deficiencies in these responses, particularly in repair of different damaged DNA are of tremendous importance in the etiology of human cancers and at the same time offer great opportunities for designing targeted therapeutic strategies. Based on transcriptome analysis, we have established gene signature that faithfully predicted the defect of homologous recombination repair (HRD), replication stress response defect (RSRD) and mismatch repair defect (MMRD) in cells. In addition, based on these signatures, we identified effective drugs that can target on cancer with these specific DNA repair defects. Our studies, therefore, provide a unique platform to develop personalized cancer therapy based on the unique deficiency of DNA repair in the individual cancer.

Shiaw-Yih Lin is a Tenured Professor and Deputy Chair of Department of Systems Biology at The University of Texas MD Anderson Cancer Center. His research efforts are focused within an overall theme of DNA damage response defects in cancer with the specific emphasis on systems and translational precision cancer therapy. He serves on Editorial Boards of 10 international journals and has served on numerous Grant Review Committees for NIH, DOD and other funding organizations both nationally and internationally.

E-mail: [email protected]


Relevant Topics